meticillin-resistant Staphylococcus aureus: a mathematical modelling study. The Lancet Infectious Diseases. 2016;16(3):348-56. 32. Borg MA, Suda D, Scicluna E, Brincat A, Zarb P. Universal admission screening: a potential game-changer in hospitals with high prevalence of MRSA. Journal of Hospital Infection. 2021;113:7784. 33. Kardaś-Słoma L, Fournier S, Dupont J-C, Rochaix L, Birgand G, Zahar J-R, et al. Costeffectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study. Antimicrobial Resistance & Infection Control. 2022;11(1):117. 34. Lapointe-Shaw L, Voruganti T, Kohler P, Thein HH, Sander B, McGeer A. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients. Eur J Clin Microbiol Infect Dis. 2017;36(6):1047-55. 35. van Dijk MD, Voor In 't Holt AF, Polinder S, Severin JA, Vos MC. The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting. J Hosp Infect. 2021;109:88-95. 36. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. 37. Gastmeier P, Stamm-Balderjahn S, Hansen S, Zuschneid I, Sohr D, Behnke M, et al. Where should one search when confronted with outbreaks of nosocomial infection? Am J Infect Control. 2006;34(9):603-5. 38. Chen LF, Knelson LP, Gergen MF, Better OM, Nicholson BP, Woods CW, et al. A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients-the TransFER study. Infect Control Hosp Epidemiol. 2019;40(1):47-52. 39. Wu YL, Yang XY, Ding XX, Li RJ, Pan MS, Zhao X, et al. Exposure to infected/colonized roommates and prior room occupants increases the risks of healthcare-associated infections with the same organism. J Hosp Infect. 2019;101(2):231-9. 40. van der Schoor AS, Boyle M, Voor In 't Holt AF, Vos MC, Humphreys H, Infections ESGfN. Environmental sampling of innate hospital surfaces: a survey of current practices and the need for guidelines. J Hosp Infect. 2022;128:92-5. 41. van der Schoor AS, Severin JA, Klaassen CHW, Gommers D, Bruno MJ, Hendriks JM, et al. Environmental contamination with highly resistant microorganisms after relocating to a new hospital building with 100% single-occupancy rooms: A prospective observational before-and-after study with a three-year follow-up. International Journal of Hygiene and Environmental Health. 2023;248:114106. 42. Rawlinson S, Ciric L, Cloutman-Green E. How to carry out microbiological sampling of healthcare environment surfaces? A review of current evidence. J Hosp Infect. 2019;103(4):363-74. 43. Hedin G, Rynbäck J, Loré B. New technique to take samples from environmental surfaces using flocked nylon swabs. Journal of Hospital Infection. 2010;75(4):314-7. 44. Snibsøer AK, Ciliska D, Yost J, Graverholt B, Nortvedt MW, Riise T, et al. Self-reported and objectively assessed knowledge of evidence-based practice terminology among healthcare students: A cross-sectional study. PLoS One. 2018;13(7):e0200313. 45. Aguirre-Raya KA, Castilla-Peón MF, Barajas-Nava LA, Torres-Rodríguez V, Muñoz-Hernández O, Garduño-Espinosa J. Self-perception and knowledge of evidence based medicine by physicians. BMC Med Educ. 2016;16:166. 46. Mody L, Washer LL, Kaye KS, Gibson K, Saint S, Reyes K, et al. Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms? Clin Infect Dis. 2019. 47. Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, et al. Assessment of the Overall and Multidrug-Resistant Organism Bioburden on Environmental Surfaces in Healthcare Facilities. Infect Control Hosp Epidemiol. 2016;37(12):1426-32. 48. Tanner WD, Leecaster MK, Zhang Y, Stratford KM, Mayer J, Visnovsky LD, et al. Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities. Clin Infect Dis. 2021;72(Suppl 1):S8-S16. 202 Chapter 4
RkJQdWJsaXNoZXIy MTk4NDMw